Literature DB >> 10451703

Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma.

D A Reardon1, R E Entrekin, J Sublett, S Ragsdale, H Li, J Boyett, J L Kepner, A T Look.   

Abstract

We analyzed 23 samples of primary pediatric ependymoma for significant gains or losses of genomic DNA, using comparative genomic hybridization (CGH) and a rigorous statistical approach. Nine of the tumors in this series (39%) appeared normal by CGH. The remainder had a limited number of regions of genomic imbalance, most often involving losses of chromosome arms 6q and 22q and the X chromosome, or gains of either 1q or 9. Recurrent and exclusive losses of 6q or 22q suggest that these regions harbor tumor suppressor genes that may contribute independently to the pathogenesis of childhood ependymoma.

Entities:  

Mesh:

Year:  1999        PMID: 10451703     DOI: 10.1002/(sici)1098-2264(199903)24:3<230::aid-gcc8>3.0.co;2-c

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  17 in total

1.  Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups.

Authors:  Sara Dyer; Emma Prebble; Val Davison; Paul Davies; Pramila Ramani; David Ellison; Richard Grundy
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies.

Authors:  Mandeep S Tamber; Krishan Bansal; Muh-Lii Liang; Todd G Mainprize; Bodour Salhia; Paul Northcott; Michael Taylor; James T Rutka
Journal:  Childs Nerv Syst       Date:  2006-09-02       Impact factor: 1.475

3.  Study of chromosome 9q gain, Notch pathway regulators and Tenascin-C in ependymomas.

Authors:  Rakesh Kumar Gupta; Mehar C Sharma; Vaishali Suri; Aanchal Kakkar; Manmohan Singh; Chitra Sarkar
Journal:  J Neurooncol       Date:  2013-11-01       Impact factor: 4.130

4.  Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.

Authors:  Y Hirose; K Aldape; A Bollen; C D James; D Brat; K Lamborn; M Berger; B G Feuerstein
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

5.  Evaluation of chromosome 1q gain in intracranial ependymomas.

Authors:  Madhu Rajeshwari; Mehar Chand Sharma; Aanchal Kakkar; Aruna Nambirajan; Vaishali Suri; Chitra Sarkar; Manmohan Singh; Ravindra Kumar Saran; Rakesh Kumar Gupta
Journal:  J Neurooncol       Date:  2016-01-02       Impact factor: 4.130

Review 6.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

Review 7.  Molecular profiling of pediatric brain tumors: insight into biology and treatment.

Authors:  Robert Johnson; Karen D Wright; Richard J Gilbertson
Journal:  Curr Oncol Rep       Date:  2009-01       Impact factor: 5.075

Review 8.  The genetic and epigenetic basis of ependymoma.

Authors:  Stephen C Mack; Michael D Taylor
Journal:  Childs Nerv Syst       Date:  2009-06-18       Impact factor: 1.475

9.  Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.

Authors:  Audrey Rousseau; Ahmed Idbaih; François Ducray; Emmanuelle Crinière; Michèle Fèvre-Montange; Anne Jouvet; Jean-Yves Delattre
Journal:  J Neurooncol       Date:  2009-10-29       Impact factor: 4.130

Review 10.  Ependymoma.

Authors:  Charles Teo; Peter Nakaji; Patricia Symons; Vivienne Tobias; Richard Cohn; Robert Smee
Journal:  Childs Nerv Syst       Date:  2003-05-22       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.